Jeffrey Guss, MD, is a board-certified psychiatrist, psychoanalyst, researcher, and teacher with over 41 years of experience. He is a Clinical Assistant Professor of Psychiatry at NYU Grossman School of Medicine and is on the faculty of the NYU Postdoctoral Program in Psychotherapy and Psychoanalysis. He was Co-Principal Investigator and Director of Psychedelic Therapy Training for the NYU School of Medicine's landmark study on psilocybin-assisted psychotherapy in the treatment of cancer-related existential distress, published in the Journal of Psychopharmacology (2016). He is currently a study therapist in the NYU study on psilocybin-assisted therapy for alcoholism, a collaborator with Yale University's psilocybin study for Major Depressive Disorder, and a study therapist with the MAPS study on MDMA-assisted therapy for PTSD. He is an Instructor and Mentor with CIIS's Center for Psychedelic Therapies. He is interested in the integration of psychedelic therapies with contemporary psychoanalytic theory and has published in Studies in Gender and Sexuality, Psychoanalysis, Culture and Society, and Psychoanalytic Dialogues.